Back to top

WELCOME TO ZACKS.COM

Zacks' 7 Strongest Buys for November, 2024

See our "best of the best" short-term stocks. Hand-picked from 220 new Strong Buys, they could be the most profitable stocks you own over the next 90 days. Recent picks have climbed as much as +67.5% in 1 month. Our new recommendations may soar just as high.

WELCOME TO ZACKS.COM

Zacks' 7 Strongest Buys for November, 2024

See our "best of the best" short-term stocks. Hand-picked from 220 new Strong Buys, they could be the most profitable stocks you own over the next 90 days. Recent picks have climbed as much as +67.5% in 1 month. Our new recommendations may soar just as high. Today's market dip makes now an ideal time to get in.

No cost. No credit card. No obligation to buy anything ever. Past performance is no guarantee of future results.
We respect your privacy. Zacks Ultimate Member? Click here.

loading...

Zacks Private Picks

Click for the easiest, most affordable way to get the 'Best of Our Best.

Click for the easiest, most affordable way to get the 'Best of Our Best.

Top Stock Reports for Netflix, Salesforce & Cisco

Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), Salesforce, Inc. (CRM) and Cisco Systems, Inc. (CSCO), as well as a micro-cap stock, BK Technologies Corp. (BKTI).

Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), Salesforce, Inc. (CRM) and Cisco Systems, Inc. (CSCO), as well as a micro-cap stock, BK Technologies Corp. (BKTI).

Leveraged ETFs for Longer-Term Investors

In this episode of ETF Spotlight, Neena Mishra speaks with Matt Markiewicz, Head of Product & Capital Markets at Tradr ETFs, about Calendar Reset Leveraged ETFs.

In this episode of ETF Spotlight, Neena Mishra speaks with Matt Markiewicz, Head of Product & Capital Markets at Tradr ETFs, about Calendar Reset Leveraged ETFs.

New Strong Buy Stocks for November 12th

This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.

This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.

This Top AI Stock Crushed Quarterly Expectations

The 2024 Q3 earnings season is slowly winding down, with just a small chunk of the S&P 500 yet to report. The period has been positive, underpinned again by a strong showing from technology.

The 2024 Q3 earnings season is slowly winding down, with just a small chunk of the S&P 500 yet to report. The period has been positive, underpinned again by a strong showing from technology.

Investment Ideas

Stocks

ETFs

Mutual Funds

Options

Earnings Analysis

More Analysis

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise
TGI 06:05 0.03 0.20 +566.67
RMTI 06:06 0.01 0.05 +400.00
APEI 16:09 0.01 0.04 +300.00
BWAY 09:34 0.01 0.04 +300.00
ETON 16:06 -0.01 0.02 +300.00

EPS Positive Surprises for Nov 12, 2024

Symbol Time Expected Reported %Surprise
SCOR 16:08 -0.94 -12.79 -1,260.64
IHS 07:28 0.11 -0.61 -654.55
SOHO 06:34 0.01 -0.04 -500.00
AMBC 16:17 0.14 -0.46 -428.57
BCAX 07:40 -0.46 -1.60 -247.83

EPS Negative Surprises for Nov 12, 2024

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consensus Estimate
SHOP 7.63% 0.29 0.27
HD 1.93% 3.71 3.64
SE 11.24% 0.66 0.59
AZN 0.66% 1.02 1.01
Trending topics module loader